From today’s research to tomorrow’s therapies
Founded in 2008 by Université de Montréal’s Institute for Research in Immunology and Cancer (IRIC), IRICoR is a key player in Quebec’s life sciences ecosystem. Its mission is to accelerate the discovery, development and commercialization of innovative therapies in oncology, immunotherapy and rare diseases.
IRICoR plays an essential role in establishing strategic partnerships with the biopharmaceutical industry or creating spin-off companies, thus facilitating the transformation of academic research projects into new therapies for the benefit of patients. Thanks to its crucial financial support, IRICoR enables researchers to bridge the gap between academic research and the business world.
Infrastructures and expertise
Facilitates and provides privileged access to IRIC/UdeM’s expertise and specialized research infrastructures and other partner institutions
Scientific and business support
Contributes to the drug development process by supporting researchers from the early phases of projects
Assets
Ensures adequate funding of projects in its portfolio and monitoring of results/milestones
Partnership – Start-ups
Identifies and implements the best IP protection and marketing strategies in order to generate investment opportunities
